Targeting oncogenic BRAF in human cancer.

Targeting oncogenic BRAF in human cancer.

Item
http://www.wikidata.org/entity/Q42020468
Signaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsPediatric lymphomas and histiocytic disorders of childhoodCanDrA: cancer-specific driver missense mutation annotation with optimized features.Induction of Resistance to BRAF Inhibitor Is Associated with the Inability of Spry2 to Inhibit BRAF-V600E Activity in BRAF Mutant CellsHow I treat Langerhans cell histiocytosis.Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial.Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arrays.Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14
P2860

Targeting oncogenic BRAF in human cancer.

Item
http://www.wikidata.org/entity/Q42020468
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting oncogenic BRAF in human cancer.
@en
Targeting oncogenic BRAF in human cancer.
@nl
type
label
Targeting oncogenic BRAF in human cancer.
@en
Targeting oncogenic BRAF in human cancer.
@nl
prefLabel
Targeting oncogenic BRAF in human cancer.
@en
Targeting oncogenic BRAF in human cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Targeting oncogenic BRAF in human cancer.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932